← Back to patent-cliff list
盐酸美金刚
Tier C — Watch / tradeMemantine Hydrochloride
Merz Pharma
Originator
2002
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：NMDAR
Brand：Balaxur、易倍申、Axura、Memary、Namenda、Akatinol、Ebixa
Indications (approved)：阿尔茨海默病
Regional status
US
临床三期
2002-06-01
EU
批准上市
2002-05-15
China
批准上市
2006-09-12
Japan
批准上市
2011-01-21
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Memantine Hydrochloride?
Approved indications include: 阿尔茨海默病.
When does the Memantine Hydrochloride patent expire?
No public expiry year is available for Memantine Hydrochloride yet; this page updates once verified.
How do I get a quote for Memantine Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25